Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Glow Stack Protocol: Peptide Comparison

This table compares peptide options across administration, half-life, primary mechanism, and optimal stacking context. MK-677 Oral 24 hours Ghrelin receptor agonist. Sustained GH/IGF-1 elevation Evening dosing as GH-axis foundation; pairs with non-GH peptides

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • This table compares peptide options across administration, half-life, primary mechanism, and optimal stacking context.
  • MK-677
  • Oral
  • 24 hours
  • Ghrelin receptor agonist. Sustained GH/IGF-1 elevation
  • Evening dosing as GH-axis foundation; pairs with non-GH peptides (SLU-PP-332, KPV, Cartalax)
  • Best for sustained anabolic base without injection; daily dosing for 3–6 months without desensitization
  • Thymalin
  • Subcutaneous
  • 4–6 hours
  • Thymic epithelial stimulation. T-cell differentiation
  • Morning dosing in 10-day cycles; avoid stacking with other immune peptides during active cycle
  • Gold standard for immune rejuvenation; pulsed cycling prevents overstimulation
  • Cerebrolysin
  • Intramuscular/IV
  • 2.5 hours (active fragments)
  • Neurotrophic factor delivery. Synaptic plasticity
  • Midday dosing in 10–20 day cycles; pairs with evening GH secretagogues
  • Clinical-grade nootropic with human trial data; requires injection
  • Dihexa
  • Subcutaneous/Oral
  • 2–4 hours
  • HGF receptor agonist. Synaptogenesis
  • Morning/early afternoon in 1–2 week pulses; combine with non-cognitive peptides
  • Extreme potency (7 orders > BDNF); short cycles with long assessment breaks
  • SLU-PP-332
  • 6–8 hours
  • Mitochondrial biogenesis via ERRα
  • Flexible timing; complements any stack without receptor competition
  • Emerging research compound; metabolic enhancement without GH pathway
  • Hexarelin
  • 70 minutes
  • GHSR-1a agonist. Acute GH pulse
  • Pre-sleep dosing on non-MK-677 days; 5-on/2-off to prevent desensitization
  • Powerful acute GH release but desensitizes faster than MK-677